The healthcare industry generates about 30% of the world’s data. However, historically this data has been locked in silos and healthcare organizations have failed to generate real-time operational and ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

A lot of teams want to use AI today, but many feel unsure about how to get their data ready for it. If the data stack is not strong, AI tools struggle. This can slow down projects and make results ...

Data Centers in Nvidia’s Hometown Stand Empty Awaiting Power The fate of two facilities in Santa Clara, California, highlights a major challenge for the US tech sector and indeed the wider economy.

Enterprise data infrastructure is at a breaking point. Organizations are drowning in complexity as they struggle to manage the increasing demands of real-time analytics, personalized customer ...

COLUMBUS, Ohio (WCMH) — The Public Utilities Commission of Ohio on Wednesday ordered AEP Ohio to file for new tariffs, or rate structures, that apply specifically to data centers in an effort to ...

Tool overload drains value. Most organizations use far more tools than they need, which leads to duplication, poor integration and underused capabilities. Governance matters. Successful teams ...

Enterprise leaders face a mounting challenge: AI infrastructure is getting increasingly complex. As companies move large language models, RAG, and autonomous agents from pilot projects to production ...

Two data center ABS deals from Stack and Compass this week should be able to piggyback off residual demand from recent fiber-backed deals, said bankers, as investors are eager to put capital to work ...

Abstract: Solid oxide fuel cells have great potential as a clean and efficient energy conversion method, especially for multi-stack systems in high-power scenarios. However, for a multi-stack system, ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...